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The transfer of extracellular RNA is emerging as an important mechanism for inter-cellular
communication. The ability for the transfer of functionally active RNA molecules from
one cell to another within vesicles such as exosomes enables a cell to modulate cellu-
lar signaling and biological processes within recipient cells. The study of extracellular RNA
requires sensitive methods for the detection of these molecules. In this methods article,
we will describe protocols for the detection of such extracellular RNA using sensitive detec-
tion technologies such as digital PCR. These protocols should be valuable to researchers
interested in the role and contribution of extracellular RNA to tumor cell biology.
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INTRODUCTION
An emerging mechanism for cell-to-cell communication involves
the transfer of biologically active RNA molecules released into the
extracellular space and that can be taken up by recipient cells.
The potential importance of this mechanism is highlighted by the
demonstration of biological effects in recipient cells both within
the local environment as well as at a distance. Several different
types of RNA may be released, and include both protein-coding
RNA as well as non-coding RNA. The latter are of particular
interest because modulation of gene expression is a key feature
of non-coding RNA such as the microRNA.
The isolation and characterization of extracellular RNA thus is
a necessary tool for understanding biological processes involving
inter-cellular communication. Extracellular RNA can be released
from cells as native RNAs, associated with proteins, or enclosed
within extracellular vesicles (EV) such as exosomes. Extracellular
RNA can be detected within EV in the circulation. Moreover, it
has been reported that microRNAs that are not enclosed within
EV can be isolated from the circulation (1–3). Extracellular RNA
is susceptible to degradation by circulating RNAses (2). However,
RNA enclosed within EV may be protected from such degrada-
tion. These EV differ in their biogenesis. They include exosomes,
microvesicles, and apoptotic bodies. In addition to RNA such as
mRNA or non-coding RNA, these vesicles may also contain pro-
teins, and lipids. They are released from a wide variety of normal
or diseased cells (4, 5). The content and postulated biological roles
of these EV may vary with the cells of origin (5, 6). Recent stud-
ies have confirmed that EV can transfer RNAs such as ncRNAs
from one cell to another and thereby contribute to important roles
in inter-cellular communication (3–9). We describe methods for
the isolation of EV obtained from human serum or from cells in
culture, and for the extracting extracellular RNA from these EV.
Detection of RNA has relied on the use of quantitative real-time
polymerase chain reaction (qPCR). Although well-established,
and robust, the use of qPCR is limited by the sensitivity in detect-
ing the small amounts of RNA that are obtained from conventional
preparations of extracellular RNA. Digital polymerase chain reac-
tion (dPCR) provides an alternative approach for the detection of
gene expression in the setting where the amount of target RNA
is low and approaching the limits of sensitivity of qPCR (10).
Recent studies have compared the two technologies and reported
improved precision and reproducibility with dPCR (11). dPCR
offers the ability to obtain absolute quantification of gene expres-
sion, thereby avoiding reliance on the need for invariant genes
(which may not be possible in the analysis of extracellular RNA). In
addition, detection using dPCR is more tolerant to PCR inhibitors
because it is based on the detection of presence or absence of a
reaction end-point.
Digital PCR involves the partitioning of a sample into multi-
ple separate reactions that result in several thousands or millions
of individual reactions. This can be accomplished through the
use of microfluidic chips or by generating microdroplets. With
droplet digital PCR (ddPCR), partitioning occurs within nano-
liter or picoliter sized droplets. The reaction undergoes end-point
PCR, and droplets will contain some copies or no copies of target
sequence of interest. These droplets are individually analyzed using
a fluorescence detector (e.g., QX100, Bio-Rad), or flow cytometry
(RainDrop, RainDance). Positive droplets are counted and used
to estimate the target concentration. The true concentration may
be underestimated because a positive droplet cannot differenti-
ate between the number of molecules present in each partition.
This can be addressed by using the Poisson equation to calcu-
late the concentration based on the number of negative droplets
and using the following formula: copies per droplet=−ln(1− p)
where p= fraction of positive droplets. Increasing the number
of partitions offers the potential to increase sensitivity for the
detection of very small amounts of targets, and can be accom-
plished through microfluidic based PCR platforms such as the
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BioMark (Fluidigm) and Open Array (Life Technologies). Increas-
ingly, dPCR is being used for various applications such as absolute
quantification, rare event detection, and copy number variation.
Therefore, the use of dPCR could be a very useful tool for the detec-
tion and quantitation of extracellular RNA. We report studies that
illustrate the use of dPCR for the detection of extracellular RNA.
MATERIALS AND METHODS
ISOLATION OF EXTRACELLULAR VESICLES
We describe herein an approach involving the use of sequential
centrifugation for the isolation of EV as an example. This approach
is based on previous reports from our laboratory and others (1,
5, 12, 13) and has been adapted for isolation of EV from cells
in culture or from serum. Isolation of specific types of EV such
as exosomes would require additional procedures. There are sev-
eral other approaches that have been used for the isolation of EV,
such as the use of affinity filtration, precipitation, or affinity-based
isolation techniques. Several commercial products based on these
approaches are available. Protocols using these approaches vary
with the type of biological sample that is being analyzed. It should
be noted that the EV preparations obtained vary with the approach
used for isolation and depending on the isolation approach used,
they may contain non-vesicular RNA or restricted EV populations.
For cells in culture, cells are cultured in media that is pre-
depleted of EV by centrifugation as follows: cell culture medium
is centrifuged at 100,000× g at 4°C overnight. The supernatant is
then filtered through a 0.22-µm filter and stored at 4°C. Cells are
cultured in EV depleted culture medium for 3–4 days. For most
isolations, we have collected EV from supernatants obtained from
at least 16 10-cm culture dishes in order to obtain a sufficient
yield for downstream studies. For isolation of EV from serum,
500µl of serum is first diluted 1:3 with cold phosphate buffered
saline (PBS).
Isolation of EV is then performed by sequential centrifuga-
tions that result in removal of cells, removal of cell debris, and
larger vesicles, and ultracentrifugation to generate a residua of EV.
The samples are first centrifuged at 300× g for 10 min, then at
2000× g for 20 min at 4°C. The supernatant is then centrifuged
at 10,000× g for 70 min at 4°C. The supernatant is further ultra-
centrifuged at 100,000× g for 70 min at 4°C, and the supernatant
is aspirated off to obtain a residual pellet containing EVs. The
pellet is re-suspended by adding 2 ml of PBS and centrifuged at
100,000× g for 70 min. The supernatant is carefully aspirated off
to obtain a pellet containing EV. The pellet is then re-suspended
in 100–500µl PBS and used for other downstream experiments
or stored at −80°C. This method provides intact EV that can be
further analyzed using nanoparticle tracking analysis (NanoSight
LM10 instrument, Amesbury, UK, or similar) or examined with
electron microscopy. If desired, isolation of pure exosomes or
other vesicle populations can be performed by density gradient
centrifugation.
ISOLATION OF RNA FROM EXTRACELLULAR VESICLES
RNA can be isolated from EV preparations using any standard
methods. We describe a protocol for isolation of RNA using TRIzol
Reagent (Life Technologies, Grand Island, NY, USA). EV prepara-
tions are obtained as reported above and diluted in 100µl PBS
are incubated for 5 min at room temperature with 1 ml of TRIzol
Reagent in a 1.5-ml RNase-free tube. Two hundred microliters
of chloroform is added and mixed well by shaking vigorously
for 30 s. The sample is then incubated for 5 min at RT and cen-
trifuged at 12,000× g for 15 min at 4°C. The upper aqueous phase
is transferred to a new 1.5 ml tube without disrupting the inter-
mediate or the bottom organic phase. Five hundred microliters of
100% isopropanol is added and incubated at−20°C for overnight.
After incubation, sample is centrifuged at 12,000× g for 60 min
at 4°C and the supernatant removed using a pipette. Six hundred
microliters of 75% ethanol is added and the sample centrifuged
at 12,000× g for 5 min. The ethanol is then removed and the step
is repeated. The ethanol is removed using a pipette and the pellet
containing RNA is air-dried prior to re-suspension in 10µl RNase-
free water. The quality of the RNA and concentration are assessed
after isolation using conventional approaches such as Nanodrop
2000 (Thermo Scientific, Wilmington, DE, USA) for quantitation.
Isolations from serum samples were based on the use of
SeraMirTM Exosome RNA Amplification Kit (System Biosciences)
after isolation of EV using Exoquick (System Biosciences).
Although the SeraMir kit contains primers for PCR amplification,
RNA was not amplified after isolation.
DIGITAL PCR FOR DETECTION AND QUANTITATION OF RNA
We describe two approaches for dPCR analysis of extracellular
RNA following reverse transcription. The first uses ddPCR (Bio-
Rad, Pleasanton, CA, USA), whereas the second uses the Raindrop
(RainDance Technologies, Lexington, MA, USA). Both approaches
are based on the use of partitioning into several discrete reaction
volumes prior to performing PCR amplification, and followed by
detection of positive reactions. An overview of extracellular RNA
detection by dPCR is provided in Figure 1.
Droplet digital PCR analysis
Droplet digital PCR is then performed using a Bio-Rad QX100
Droplet Digital PCR system (Bio-Rad). Reactions are performed
in appropriate volumes using 10µl ddPCR 2× Master Mix, 1µl
20× Primer and TaqMan Probe Mix, 5µl Nuclease free water, and
4µl reverse transcriptase product. Sample is loaded into a droplet
generator cartridge. Twenty microliters of preparation sample is
then transferred into the cartridge’s middle wells, being careful to
avoid bubbles. Seventy microliters of oil is added into lower wells
and the sample containing cartridge placed into the droplet gener-
ator to generate individual droplets. Once the process is complete,
35µl droplets are transferred into columns of a 96-well PCR plate,
sealed, and loaded into a thermal cycler. The following program
is run: 95°C for 10 min, followed by 40 cycles of 94°C for 30 s
and 60°C for 1 min, followed by 98°C for 10 min. After PCR is
complete, the sealed plate is loaded into the droplet reader for
detection of completed PCR reactions in individual droplets. The
data is analyzed using the QuantaSoft software (Bio-Rad) with
the thresholds for detection set manually based on results from
negative control wells containing water instead of RNA.
RainDrop dPCR assay
Digital polymerase chain reaction reactions are prepared in 50µl
final volume, using 25µl TaqMan Master Mix II (2×), no UNG
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FIGURE 1 | Overview of extracellular RNA detection by dPCR.
Extracellular vesicles can be collected from cells in culture or serum. RNA is
isolated from the vesicles and PCR reaction is prepared with cDNA template.
Samples are partitioned into nanoliter or picoliter droplets and undergo
end-point PCR. Fluorescence is measured in each partition and absolute
quantitation is determined by analyzing positive and negative droplets.
(Life Technologies), 5µl Droplet Stabilizer (RainDance Technolo-
gies), 2.5µl TaqMan Assay Mix (20×), 13.5µl nuclease free water,
and 4µl cDNA template. Droplets are generated using Rain-
Drop Source chip (RainDance Technologies) and deposited into
PCR tubes. PCR tubes are transferred into a thermal cycler and
processed using the following parameters: 10 min 95°C, then 45
cycles of 95°C for 15 s and 60°C for 1 min with a ramping speed
of 0.5°C/s, followed by 98°C for 10 min. After PCR completion,
tubes are transferred into RainDrop Sense chip (RainDance Tech-
nologies) for fluorescence measurements. The RainDrop Analyst
Software (RainDance Technologies) is used to analyze the data set
to define thresholds and count droplets. Gating is performed on
negative control sample and applied for all samples from the same
experiment.
RESULTS
DETECTION AND QUANTITATION OF SYNTHETIC miRNA
To demonstrate the ability of dPCR for detection of extracellu-
lar RNA, studies were performed using an exogenous synthetic
microRNA, cel-miR-39. Reverse transcription was performed
using 30 ng of cel-miR-39 and cDNA generated. Various dilu-
tions of cDNA were then analyzed using the QX100 (Bio-Rad) or
RainDrop (RainDance Technologies) as described in the Section
“Materials and Methods” (Figure 2). These studies demonstrate
the ability of dPCR to detect input RNA amounts as low as 0.01 pg.
DETECTION AND QUANTITATION OF ENDOGENOUS microRNA IN EV
AND IN THEIR DONOR CELLS
To examine the ability of dPCR to detect endogenous non-coding
RNA within EV, we examined the expression of miR-29b in HepG2
human hepatocellular cancer cells and within EV derived from
these cells. miR-29 can regulate expression of MEG3, a tumor
suppressive lncRNA, and miR-29 expression was down regulated
in human HCC cells (14). EV RNA was isolated from HepG2
donor cells, and from EV released by these cells as described in
the section “Materials and Methods.” Briefly, cells were plated in
vesicle-depleted medium on 16 collagen-coated 10 cm dishes at
~70% confluency for 3–4 days. Supernatant was collected, and EV
isolated using differential ultracentrifugation, and RNA isolated
from EV preparations as described above. RNA isolation was also
performed from donor cells using Trizol. 795.3 ng of RNA was
isolated from 6985× 106 particles as quantitated by nanoparti-
cle tracking analysis using Nanosight. cDNA was generated by
reverse transcription using 132.5 ng of RNA per reaction in a 15-
µl volume. ddPCR was performed using 1 ng cDNA per ddPCR
reaction in a volume of 20µl. The concentration of miR-29 in EV
was 0.6 copies/µl, and was decreased compared with that in donor
cells (Figure 3). Based on the measured 12 copies of miR-29 per
1 ng of cDNA, we estimate a minimum of 1.4 copies of miR-29
per 106 vesicles on average. Although the expression of miR-29b
expression was very low in EV, their detection was possible with
ddPCR.
DETECTION AND QUANTITATION OF AN EXTRACELLULAR lncRNA IN
HUMAN SERUM
The ability to detect circulating tumor cell derived extracellular
RNA is necessary to enable their use as biomarkers of disease.
EV derived RNA was isolated from 1 ml of human serum using
Exoquick (System Biosciences) and SeraMir™ Exosome RNA
Amplification Kit (System Biosciences). RNA yield was deter-
mined using Nanodrop and a total of 183 ng RNA was obtained.
cDNA was obtained using reverse transcriptase. Serial dilutions
of cDNA were made and samples were analyzed using RT-qPCR
or ddPCR analysis. To evaluate the expression of circulating long
non-coding RNA within EV, we analyzed the expression of the
long non-coding RNAs lncRNA 21A and NDM29 (Figure 4).
We also analyzed expression of TUC339, a long non-coding
RNA that is selectively released in EV from hepatocellular can-
cer cells and is foundationally implicated in modulating tumor
cell behavior (15). TUC339 was not detected in EV derived
from human serum by TaqMan RT-qPCR, but could be detected
by ddPCR with input RNA amounts as low as 0.5 ng/µl (data
not shown). Thus ddPCR may be useful as an end-point assay
to detect the presence of very low expression genes that may
have biological or translational potential but cannot be detected
by qPCR.
DISCUSSION
We have described methods for measuring extracellular ncRNA
expression using dPCR in isolated EV from human serum sam-
ples and from cell supernatants. Due to limited sample size and
low abundance of extracellular RNA, a sensitive method of mea-
suring gene expression such as dPCR is necessary. dPCR has
an advantage for studies where the target of interest is limited
or present in low quantities that cannot reliably be detected
using qPCR. In addition, dPCR provides absolute quantification.
www.frontiersin.org June 2014 | Volume 4 | Article 129 | 3
Takahashi et al. exRNA analysis using digital PCR
FIGURE 2 | Detection and quantitation of synthetic microRNA using
dPCR. (A) Fluorescence amplitude of cel-miR-39 from different
concentrations of RNA using the QX100 (BioRad). cDNA was transcribed
using iScript cDNA synthesis kit (BioRad, Hercules, CA, USA) in a 10-µl
reaction volume. cDNA was diluted to 5, 1, 0.1, and 0.01 pg. Samples
were partitioned using the Droplet Generator (Bio-Rad). PCR was
performed using cel-miR-39 TaqMan Assay kit (Life Technologies). Droplets
were thermal cycled to end-point and fluorescence measurement was
read using Droplet Reader (Bio-Rad). Results were analyzed using
QuantaSoft (Bio-Rad). (B) Fluorescence amplitude of cel-miR-39 from
different concentrations of RNA using the RainDrop. cDNA was
transcribed from cel-miR-39 using TaqMan MicroRNA cDNA synthesis kit
(Life Technologies, Carlsbad, CA, USA) in a 15-µl reaction. The RT reaction
was performed using a ProFlex PCR system (Life Technologies) and the
following conditions: 4°C for 5 min, 16°C for 30 min, 42°C for 30 min, 85°C
for 5 min, and hold at 4°C. cDNA was diluted to 5, 1.25, 0.15, and 0.078 pg
dilutions. Samples were partitioned using the RainDrop Source Chip
(RainDance), and PCR performed. Droplets were thermal cycled to
end-point and fluorescence measurement was read using RainDrop Sense
Chip (RainDance). Results were analyzed using RainDrop Analyst
(RainDance). The amount of input RNA is reported in the top, whereas the
number of positive/negative droplets are reported on the bottom of each
panel. The bottom panels depict the relationship between calculated
copies/microliter and input RNA.
The use of dPCR offers high sensitivity and enables absolute
quantitation of low abundance transcripts that may be present
within EV.
The ability to analyze extracellular RNA is essential for the
potential application of extracellular RNA as biomarkers for early
diagnosis, or as prognostic markers of disease. For human cancers,
tumor-specific changes in EV RNA content could be potentially
used, but such applications require sensitive and accurate deter-
mination of their RNA content. The approaches described herein
may provide a dPCR based method that could be used for detecting
the presence and for quantitating circulating RNA, or RNA within
EV released from cells in culture. The use of dPCR could be a very
useful tool for the detection and quantitation of RNA biomark-
ers in the clinic. In order to accomplish this, further development
of dPCR based assays and standardization is required. As a first
step toward this, guidelines for digital MIQE have been proposed
(16). In other applications, dPCR has been shown to be able to pro-
vide precise estimates of DNA copy number with high-throughput
capabilities. Therefore, we expect that further application and
refinement of the approaches described will be useful for analy-
sis of extracellular RNA as potential disease markers for human
cancers and other diseases.
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FIGURE 3 | Detection and quantitation of miR-29 in tumor cells and in EV
derived from these cells. RNA was extracted from HepG2 cells using TRIzol
and from extracellular vesicles derived from these cells using ExoQuick and
SeraMir (System Biosciences). For ddPCR, cDNA was generated from
132.5 ng RNA by reverse transcription. Four microliters of template cDNA was
used for droplet digital PCR. Samples were partitioned using the Droplet
Generator (Bio-Rad) and thermal cycled to end-point. PCR reaction was read
using Droplet Reader (Bio-Rad) and results were analyzed using QuantaSoft
(Bio-Rad). Fluorescence amplitude of droplets containing miR-29 in
(A) HepG2 cells and (B) HepG2 EV RNA from four samples each. The average
concentration of miR-29 is represented in copies/microliter, with upper and
lower Poisson confidence levels.
FIGURE 4 | Detection and quantitation of lncRNA in serum. Extracellular
RNA was isolated from human serum using ExoQuick and SeraMir (System
Biosciences). A total of 200 ng RNA was used for RT and template cDNA was
diluted to 2, 1, 0.5, and 0.25 ng for PCR. Samples were partitioned using the
Droplet Generator (Bio-Rad) and thermal cycled to end-point using primers
specific for lncRNA 21A or for NDM29. PCR reaction was read using Droplet
Reader (Bio-Rad) and results were analyzed using QuantaSoft (Bio-Rad). The
concentration of each lncRNA is expressed in copies/microliter for different
amounts of input RNA with error bars representing upper and lower Poisson
confidence limits (n=4 replicates).
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